- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan RNAi for Therapeutic market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan RNAi for Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by RNAi for Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Alnylam Pharmaceuticals Research
Creative Animodel
Celsion Corporation
Ensysce Biosciences
Sylentis
miRagen Therapeutics Incorporated
Arbutus Biopharma (Tekmira)
AstraZeneca
Celgene
Silence Therapeutics
Ascletis Pharmaceuticals
Bayer Heathcare
CombiMatrix
Astellas Pharma
Biogazelle
RXi Pharmaceuticals
Tekmira Pharmaceuticals.
Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Silenseed
Benitec Biopharma
Calando Pharmaceuticals
BioSpring
GeneCopoeia
Gradalis
By Type:
siRNA
miRNA
shRNA
By End-User:
Cancer
Cardiovascular
HBV
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNAi for Therapeutic Market
-
1.3 Market Segment by Type
1.3.1 Japan RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
1.3.2 Japan RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
1.3.3 Japan RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
1.4.2 Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
1.4.3 Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
1.4.4 Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of RNAi for Therapeutic Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNAi for Therapeutic by Major Types
3.4.1 Market Size and Growth Rate of siRNA
3.4.2 Market Size and Growth Rate of miRNA
3.4.3 Market Size and Growth Rate of shRNA
4 Segmentation of RNAi for Therapeutic Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNAi for Therapeutic by Major End-Users
4.4.1 Market Size and Growth Rate of RNAi for Therapeutic in Cancer
4.4.2 Market Size and Growth Rate of RNAi for Therapeutic in Cardiovascular
4.4.3 Market Size and Growth Rate of RNAi for Therapeutic in HBV
4.4.4 Market Size and Growth Rate of RNAi for Therapeutic in Others
5 Market Analysis by Regions
-
5.1 Japan RNAi for Therapeutic Production Analysis by Regions
-
5.2 Japan RNAi for Therapeutic Consumption Analysis by Regions
6 Hokkaido RNAi for Therapeutic Landscape Analysis
-
6.1 Hokkaido RNAi for Therapeutic Landscape Analysis by Major Types
-
6.2 Hokkaido RNAi for Therapeutic Landscape Analysis by Major End-Users
7 Tohoku RNAi for Therapeutic Landscape Analysis
-
7.1 Tohoku RNAi for Therapeutic Landscape Analysis by Major Types
-
7.2 Tohoku RNAi for Therapeutic Landscape Analysis by Major End-Users
8 Kanto RNAi for Therapeutic Landscape Analysis
-
8.1 Kanto RNAi for Therapeutic Landscape Analysis by Major Types
-
8.2 Kanto RNAi for Therapeutic Landscape Analysis by Major End-Users
9 Chubu RNAi for Therapeutic Landscape Analysis
-
9.1 Chubu RNAi for Therapeutic Landscape Analysis by Major Types
-
9.2 Chubu RNAi for Therapeutic Landscape Analysis by Major End-Users
10 Kinki RNAi for Therapeutic Landscape Analysis
-
10.1 Kinki RNAi for Therapeutic Landscape Analysis by Major Types
-
10.2 Kinki RNAi for Therapeutic Landscape Analysis by Major End-Users
11 Chugoku RNAi for Therapeutic Landscape Analysis
-
11.1 Chugoku RNAi for Therapeutic Landscape Analysis by Major Types
-
11.2 Chugoku RNAi for Therapeutic Landscape Analysis by Major End-Users
12 Shikoku RNAi for Therapeutic Landscape Analysis
-
12.1 Shikoku RNAi for Therapeutic Landscape Analysis by Major Types
-
12.2 Shikoku RNAi for Therapeutic Landscape Analysis by Major End-Users
13 Kyushu RNAi for Therapeutic Landscape Analysis
-
13.1 Kyushu RNAi for Therapeutic Landscape Analysis by Major Types
-
13.2 Kyushu RNAi for Therapeutic Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Alnylam Pharmaceuticals Research
14.1.1 Alnylam Pharmaceuticals Research Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Creative Animodel
14.2.1 Creative Animodel Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Celsion Corporation
14.3.1 Celsion Corporation Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Ensysce Biosciences
14.4.1 Ensysce Biosciences Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Sylentis
14.5.1 Sylentis Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 miRagen Therapeutics Incorporated
14.6.1 miRagen Therapeutics Incorporated Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Arbutus Biopharma (Tekmira)
14.7.1 Arbutus Biopharma (Tekmira) Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 AstraZeneca
14.8.1 AstraZeneca Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Celgene
14.9.1 Celgene Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Silence Therapeutics
14.10.1 Silence Therapeutics Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Ascletis Pharmaceuticals
14.11.1 Ascletis Pharmaceuticals Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Bayer Heathcare
14.12.1 Bayer Heathcare Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 CombiMatrix
14.13.1 CombiMatrix Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 Astellas Pharma
14.14.1 Astellas Pharma Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 Biogazelle
14.15.1 Biogazelle Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
14.16 RXi Pharmaceuticals
14.16.1 RXi Pharmaceuticals Company Profile and Recent Development
14.16.2 Market Performance
14.16.3 Product and Service Introduction
14.17 Tekmira Pharmaceuticals.
14.17.1 Tekmira Pharmaceuticals. Company Profile and Recent Development
14.17.2 Market Performance
14.17.3 Product and Service Introduction
14.18 Roche Innovation Center Copenhagen (formerly Santaris Pharma)
14.18.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Company Profile and Recent Development
14.18.2 Market Performance
14.18.3 Product and Service Introduction
14.19 Silenseed
14.19.1 Silenseed Company Profile and Recent Development
14.19.2 Market Performance
14.19.3 Product and Service Introduction
14.20 Benitec Biopharma
14.20.1 Benitec Biopharma Company Profile and Recent Development
14.20.2 Market Performance
14.20.3 Product and Service Introduction
14.21 Calando Pharmaceuticals
14.21.1 Calando Pharmaceuticals Company Profile and Recent Development
14.21.2 Market Performance
14.21.3 Product and Service Introduction
14.22 BioSpring
14.22.1 BioSpring Company Profile and Recent Development
14.22.2 Market Performance
14.22.3 Product and Service Introduction
14.23 GeneCopoeia
14.23.1 GeneCopoeia Company Profile and Recent Development
14.23.2 Market Performance
14.23.3 Product and Service Introduction
14.24 Gradalis
14.24.1 Gradalis Company Profile and Recent Development
14.24.2 Market Performance
14.24.3 Product and Service Introduction
The List of Tables and Figures (Totals 142 Figures and 167 Tables)
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of siRNA from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of miRNA from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of shRNA from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu RNAi for Therapeutic Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of RNAi for Therapeutic Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of RNAi for Therapeutic
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNAi for Therapeutic by Different Types from 2014 to 2026
-
Table Consumption Share of RNAi for Therapeutic by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of siRNA
Figure Market Size and Growth Rate of miRNA
Figure Market Size and Growth Rate of shRNA
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of RNAi for Therapeutic by Different End-Users from 2014 to 2026
-
Table Consumption Share of RNAi for Therapeutic by Different End-Users from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Cardiovascular from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of HBV from 2014 to 2026
Figure Japan RNAi for Therapeutic Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan RNAi for Therapeutic Production by Regions
-
Table Japan RNAi for Therapeutic Production Share by Regions
-
Figure Japan RNAi for Therapeutic Production Share by Regions in 2014
-
Figure Japan RNAi for Therapeutic Production Share by Regions in 2018
-
Figure Japan RNAi for Therapeutic Production Share by Regions in 2026
-
Table Japan RNAi for Therapeutic Consumption by Regions
-
Table Japan RNAi for Therapeutic Consumption Share by Regions
-
Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2014
-
Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2018
-
Figure Japan RNAi for Therapeutic Consumption Share by Regions in 2026
-
Table Hokkaido RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Hokkaido RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Hokkaido RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Hokkaido RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Hokkaido RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Tohoku RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Tohoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Tohoku RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Tohoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Tohoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Tohoku RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Kanto RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Kanto RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Kanto RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Kanto RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kanto RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Kanto RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Chubu RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Chubu RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Chubu RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Chubu RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Chubu RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Chubu RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Kinki RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Kinki RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Kinki RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Kinki RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kinki RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Kinki RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Chugoku RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Chugoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Chugoku RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Chugoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Chugoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Chugoku RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Shikoku RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Shikoku RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Shikoku RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Shikoku RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Shikoku RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Shikoku RNAi for Therapeutic Consumption Share by End-Users in 2026
-
Table Kyushu RNAi for Therapeutic Consumption by Types from 2014 to 2026
-
Table Kyushu RNAi for Therapeutic Consumption Share by Types from 2014 to 2026
-
Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2014
-
Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2018
-
Figure Kyushu RNAi for Therapeutic Consumption Share by Types in 2026
-
Table Kyushu RNAi for Therapeutic Consumption by End-Users from 2014 to 2026
-
Table Kyushu RNAi for Therapeutic Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2014
-
Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2018
-
Figure Kyushu RNAi for Therapeutic Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Alnylam Pharmaceuticals Research
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals Research
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals Research
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals Research
Table Product and Service Introduction of Alnylam Pharmaceuticals Research
Table Company Profile and Development Status of Creative Animodel
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Creative Animodel
Figure Sales and Growth Rate Analysis of Creative Animodel
Figure Revenue and Market Share Analysis of Creative Animodel
Table Product and Service Introduction of Creative Animodel
Table Company Profile and Development Status of Celsion Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celsion Corporation
Figure Sales and Growth Rate Analysis of Celsion Corporation
Figure Revenue and Market Share Analysis of Celsion Corporation
Table Product and Service Introduction of Celsion Corporation
Table Company Profile and Development Status of Ensysce Biosciences
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ensysce Biosciences
Figure Sales and Growth Rate Analysis of Ensysce Biosciences
Figure Revenue and Market Share Analysis of Ensysce Biosciences
Table Product and Service Introduction of Ensysce Biosciences
Table Company Profile and Development Status of Sylentis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sylentis
Figure Sales and Growth Rate Analysis of Sylentis
Figure Revenue and Market Share Analysis of Sylentis
Table Product and Service Introduction of Sylentis
Table Company Profile and Development Status of miRagen Therapeutics Incorporated
Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics Incorporated
Figure Sales and Growth Rate Analysis of miRagen Therapeutics Incorporated
Figure Revenue and Market Share Analysis of miRagen Therapeutics Incorporated
Table Product and Service Introduction of miRagen Therapeutics Incorporated
Table Company Profile and Development Status of Arbutus Biopharma (Tekmira)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arbutus Biopharma (Tekmira)
Figure Sales and Growth Rate Analysis of Arbutus Biopharma (Tekmira)
Figure Revenue and Market Share Analysis of Arbutus Biopharma (Tekmira)
Table Product and Service Introduction of Arbutus Biopharma (Tekmira)
Table Company Profile and Development Status of AstraZeneca
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
Figure Sales and Growth Rate Analysis of AstraZeneca
Figure Revenue and Market Share Analysis of AstraZeneca
Table Product and Service Introduction of AstraZeneca
Table Company Profile and Development Status of Celgene
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
Figure Sales and Growth Rate Analysis of Celgene
Figure Revenue and Market Share Analysis of Celgene
Table Product and Service Introduction of Celgene
Table Company Profile and Development Status of Silence Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics
Figure Sales and Growth Rate Analysis of Silence Therapeutics
Figure Revenue and Market Share Analysis of Silence Therapeutics
Table Product and Service Introduction of Silence Therapeutics
Table Company Profile and Development Status of Ascletis Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ascletis Pharmaceuticals
Figure Sales and Growth Rate Analysis of Ascletis Pharmaceuticals
Figure Revenue and Market Share Analysis of Ascletis Pharmaceuticals
Table Product and Service Introduction of Ascletis Pharmaceuticals
Table Company Profile and Development Status of Bayer Heathcare
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Heathcare
Figure Sales and Growth Rate Analysis of Bayer Heathcare
Figure Revenue and Market Share Analysis of Bayer Heathcare
Table Product and Service Introduction of Bayer Heathcare
Table Company Profile and Development Status of CombiMatrix
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CombiMatrix
Figure Sales and Growth Rate Analysis of CombiMatrix
Figure Revenue and Market Share Analysis of CombiMatrix
Table Product and Service Introduction of CombiMatrix
Table Company Profile and Development Status of Astellas Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
Figure Sales and Growth Rate Analysis of Astellas Pharma
Figure Revenue and Market Share Analysis of Astellas Pharma
Table Product and Service Introduction of Astellas Pharma
Table Company Profile and Development Status of Biogazelle
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogazelle
Figure Sales and Growth Rate Analysis of Biogazelle
Figure Revenue and Market Share Analysis of Biogazelle
Table Product and Service Introduction of Biogazelle
Table Company Profile and Development Status of RXi Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi Pharmaceuticals
Figure Sales and Growth Rate Analysis of RXi Pharmaceuticals
Figure Revenue and Market Share Analysis of RXi Pharmaceuticals
Table Product and Service Introduction of RXi Pharmaceuticals
Table Company Profile and Development Status of Tekmira Pharmaceuticals.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira Pharmaceuticals.
Figure Sales and Growth Rate Analysis of Tekmira Pharmaceuticals.
Figure Revenue and Market Share Analysis of Tekmira Pharmaceuticals.
Table Product and Service Introduction of Tekmira Pharmaceuticals.
Table Company Profile and Development Status of Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Figure Sales and Growth Rate Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Figure Revenue and Market Share Analysis of Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Table Product and Service Introduction of Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Table Company Profile and Development Status of Silenseed
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silenseed
Figure Sales and Growth Rate Analysis of Silenseed
Figure Revenue and Market Share Analysis of Silenseed
Table Product and Service Introduction of Silenseed
Table Company Profile and Development Status of Benitec Biopharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma
Figure Sales and Growth Rate Analysis of Benitec Biopharma
Figure Revenue and Market Share Analysis of Benitec Biopharma
Table Product and Service Introduction of Benitec Biopharma
Table Company Profile and Development Status of Calando Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calando Pharmaceuticals
Figure Sales and Growth Rate Analysis of Calando Pharmaceuticals
Figure Revenue and Market Share Analysis of Calando Pharmaceuticals
Table Product and Service Introduction of Calando Pharmaceuticals
Table Company Profile and Development Status of BioSpring
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioSpring
Figure Sales and Growth Rate Analysis of BioSpring
Figure Revenue and Market Share Analysis of BioSpring
Table Product and Service Introduction of BioSpring
Table Company Profile and Development Status of GeneCopoeia
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GeneCopoeia
Figure Sales and Growth Rate Analysis of GeneCopoeia
Figure Revenue and Market Share Analysis of GeneCopoeia
Table Product and Service Introduction of GeneCopoeia
Table Company Profile and Development Status of Gradalis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis
Figure Sales and Growth Rate Analysis of Gradalis
Figure Revenue and Market Share Analysis of Gradalis
Table Product and Service Introduction of Gradalis
-